| 标题 |
Anemia is an independent risk factor for progression to end-stage renal disease (ESRD) in type 2 diabetics with nephropathy: results from the reduction in endpoints in non-insulin dependent diabetes mellitus with the angiotensin II antagonist losartan (RENAAL) trial 贫血是2型糖尿病肾病患者进展为终末期肾病(ESRD)的独立危险因素:血管紧张素II拮抗剂氯沙坦(RENAAL)治疗非胰岛素依赖型糖尿病终点降低的结果
|
| 网址 | |
| DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)